Clinical and Preclinical Support for Radiopharmaceuticals

The CMIE investment leverages the Centre for Probe Development and Commercialization’s radiopharmaceutical expertise to support companies and academic researchers in the development of diagnostic and therapeutic products. Specifically, this project will pursue the following objectives:

  • Advance and fund promising research or development projects through preclinical studies, GMP manufacturing process, IND filings and clinical trials pursuant to Health Canada and FDA regulations; and
  • Establish and implement an approach for the cGMP production of lutetium-177 for clinical trials, and advise and produce other emerging cGMP radioisotope.